HIF1A and muscular dystrophy: Studies on miR-424 showed that it is associated with therapeutic targets for a variety of diseases, such as muscular dystrophy, liver cancer, HPV, and vascular remodeling as well as regulating the STAT, NOTCH, and HIF1A signaling pathways (59–62).